17523 results
-
List item
Human medicine European public assessment report (EPAR): Delstrigo (updated)
doravirine, lamivudine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 22/11/2018,
, Revision: 5, Authorised, Last updated: 14/07/2020
-
List item
Human medicine European public assessment report (EPAR): Talzenna (updated)
talazoparib, Breast Neoplasms
Date of authorisation: 20/06/2019,, Revision: 2, Authorised, Last updated: 14/07/2020
-
List item
Committee for Advanced Therapies (CAT): 15-17 July 2020 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 15/07/2020 to 17/07/2020, Last updated: 14/07/2020 -
List item
Human medicine European public assessment report (EPAR): Qtrilmet (updated)
metformin hydrochloride, Saxagliptin, dapagliflozin, Diabetes Mellitus, Type 2
Date of authorisation: 11/11/2019, Revision: 2, Authorised, Last updated: 14/07/2020 -
List item
Veterinary medicine European public assessment report (EPAR): UpCard (updated)
Torasemide anhydrous, Dogs
Date of authorisation: 31/07/2015, Revision: 1, Authorised, Last updated: 14/07/2020 -
List item
Committee for Medicinal Products for Veterinary Use (CVMP): 14-16 July 2020 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 14/07/2020 to 16/07/2020, Last updated: 14/07/2020 -
List item
Human medicine European public assessment report (EPAR): Cabometyx (updated)
cabozantinib s-malate, Carcinoma, Renal Cell
Date of authorisation: 09/09/2016,, 
, Revision: 8, Authorised, Last updated: 14/07/2020
-
List item
Human medicine European public assessment report (EPAR): Tecentriq (updated)
atezolizumab, Carcinoma, Transitional Cell, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 20/09/2017,, Revision: 9, Authorised, Last updated: 13/07/2020
-
List item
Human medicine European public assessment report (EPAR): Dynastat (updated)
parecoxib sodium, Pain, Postoperative
Date of authorisation: 22/03/2002, Revision: 30, Authorised, Last updated: 13/07/2020 -
List item
Human medicine European public assessment report (EPAR): Mektovi (updated)
binimetinib, Melanoma
Date of authorisation: 20/09/2018,, Revision: 3, Authorised, Last updated: 13/07/2020
-
List item
Human medicine European public assessment report (EPAR): Kinzalkomb (updated)
telmisartan, hydrochlorothiazide, Hypertension
Date of authorisation: 19/04/2002, Revision: 36, Authorised, Last updated: 13/07/2020 -
List item
Committee for Orphan Medicinal Products (COMP): 14-16 July 2020 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 14/07/2020 to 16/07/2020, Last updated: 13/07/2020 -
List item
Plasma master file certificates (updated)
Last updated: 13/07/2020 -
List item
Workshop on the application of the General Data Protection Regulation (GDPR) in the area of health and Secondary Use of Data for Medicines and Public Health Purposes
Virtual meeting, 23/09/2020, Last updated: 13/07/2020 -
List item
Procurement (updated)
Last updated: 13/07/2020 -
List item
Orphan designation: Humanised Fc engineered monoclonal antibody against CD19, active ingredient tafasitamab for: Treatment of diffuse large B-cell lymphoma (updated)
Date of first decision: 15/01/2015, Positive, Last updated: 13/07/2020 -
List item
Human medicine European public assessment report (EPAR): Hopveus (updated)
sodium oxybate, Substance Withdrawal Syndrome, Alcohol Abstinence
Date of refusal: 06/07/2020, Refused, Last updated: 13/07/2020 -
List item
Human medicine European public assessment report (EPAR): Glivec (updated)
imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Gastrointestinal Stromal Tumors, Dermatofibrosarcoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hypereosinophilic Syndrome
Date of authorisation: 07/11/2001,, Revision: 38, Authorised, Last updated: 13/07/2020
-
List item
Human medicine European public assessment report (EPAR): Zyclara (updated)
imiquimod, Keratosis, Keratosis, Actinic
Date of authorisation: 23/08/2012, Revision: 9, Authorised, Last updated: 13/07/2020 -
List item
Human medicine European public assessment report (EPAR): Verkazia (updated)
ciclosporin, Conjunctivitis, Keratitis
Date of authorisation: 06/07/2018,, 
, Revision: 4, Authorised, Last updated: 10/07/2020
-
List item
Veterinary medicine European public assessment report (EPAR): Gumbohatch (updated)
live attenuated infectious bursal disease virus (IBDV), strain 1052, Chicken, Embryonated chicken eggs
Date of authorisation: 12/11/2019, Revision: 1, Authorised, Last updated: 10/07/2020 -
List item
Human medicine European public assessment report (EPAR): Truvada (updated)
emtricitabine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 20/02/2005, Revision: 42, Authorised, Last updated: 10/07/2020 -
List item
Human medicine European public assessment report (EPAR): Myfenax (updated)
mycophenolate mofetil, Graft Rejection
Date of authorisation: 21/02/2008,
, Revision: 22, Authorised, Last updated: 10/07/2020
-
List item
Human medicine European public assessment report (EPAR): Juluca (updated)
dolutegravir sodium, rilpivirine hydrochloride, HIV Infections
Date of authorisation: 16/05/2018,, Revision: 3, Authorised, Last updated: 10/07/2020
-
List item
Human medicine European public assessment report (EPAR): Aripiprazole Sandoz (updated)
aripiprazole, Schizophrenia, Bipolar Disorder
Date of authorisation: 20/08/2015,, Revision: 8, Authorised, Last updated: 10/07/2020